Literature DB >> 11052180

The role of polar and facial amphipathic character in determining lipopolysaccharide-binding properties in synthetic cationic peptides.

S A David1, S K Awasthi, P Balaram.   

Abstract

Two series of peptides, designated K and NK were synthesized and tested for lipid A binding and neutralizing properties. K2, which has an 11-residue amphiphilic core, and a branched N-terminus bearing two branched lysinyl residues does not bind lipid A, while NK2, also with an 11-residue amphiphilic core comprised entirely of non-ionizable residues, and a similarly branched, cationic N-terminus, binds lipid A very weakly. Both peptides do not inhibit lipopolysaccharide (LPS) activity in the Limulus assay, nor do they inhibit LPS-induced TNF-alpha and NO production in J774 cells. These results are entirely unlike a homologous peptide with an exclusively hydrophobic core whose LPS-binding and neutralizing properties are very similar to that of polymyxin B [David SA, Awasthi SK, Wiese A et al. Characterization of the interactions of a polycationic, amphiphilic, terminally branched oligopeptide with lipid A and lipopolysaccharide from the deep rough mutant of Salmonella minnesota. J Endotoxin Res 1996; 3: 369-379]. These data suggest that a clear segregation of charged and apolar domains is crucial in molecules designed for purposes of LPS sequestration and that head-tail (polar) orientation of the cationic/hydrophobic regions is preferable to molecules with mixed or facial cationic/amphipathic character.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052180

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  7 in total

1.  Anti-endotoxin agents. 2. Pilot high-throughput screening for novel lipopolysaccharide-recognizing motifs in small molecules.

Authors:  Stewart J Wood; Kelly A Miller; Sunil A David
Journal:  Comb Chem High Throughput Screen       Date:  2004-12       Impact factor: 1.339

2.  Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains.

Authors:  Ramamourthy Gopal; Young Gwon Kim; Jun Ho Lee; Seog Ki Lee; Jeong Don Chae; Byoung Kwan Son; Chang Ho Seo; Yoonkyung Park
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

3.  Anti-endotoxin agents. 1. Development of a fluorescent probe displacement method optimized for the rapid identification of lipopolysaccharide-binding agents.

Authors:  Stewart J Wood; Kelly A Miller; Sunil A David
Journal:  Comb Chem High Throughput Screen       Date:  2004-05       Impact factor: 1.339

4.  Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsis.

Authors:  Chieh-Yu Pan; Jian-Chyi Chen; Jenn-Feng Sheen; Tai-Lang Lin; Jyh-Yih Chen
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

5.  Efficient biosynthesis of a Cecropin A-melittin mutant in Bacillus subtilis WB700.

Authors:  Shengyue Ji; Weili Li; Abdul Rasheed Baloch; Meng Wang; Hengxin Li; Binyun Cao; Hongfu Zhang
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

6.  Blood Compatibility-An Important but Often Forgotten Aspect of the Characterization of Antimicrobial Peptides for Clinical Application.

Authors:  Stephan Harm; Karl Lohner; Ute Fichtinger; Claudia Schildböck; Jennifer Zottl; Jens Hartmann
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

7.  An in vitro study on factors affecting endotoxin neutralization in human plasma using the Limulus amebocyte lysate test.

Authors:  Stephan Harm; Claudia Schildböck; Karin Strobl; Jens Hartmann
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.